[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_95":96},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","hqriajwln432riu7ut3b2cpoh","revision",2,"title","Biophytis S.A. 提交 6-K，附半年度财务报告","originalTitle","6-K - Biophytis SA (0001768946) (Filer)","summary","Biophytis S.A. 于 10 月 30 日发布半年度财务报告，并将报告作为附件提交至 Form 6-K。该文件于 11 月 2 日签署，列明附件为 Exhibit 99.1。","reason","source",{"_11":85,"_86":87,"_88":89,"_90":57,"_91":92,"_93":94},"links",{"_82":83,"_63":84},"publishedAt","2026-11-02T13:34:35.000Z","discoveredAt","2026-11-03T04:44:13.469Z","timelineAt","category","ai-products","tags",[80,81],"stockSymbols",[],"score",14,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fbGzeJa8U5ZM",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","604e3570-b740-46b6-9f4a-da46de1480fb","Biophytis披露2026年上半年业绩及半年度报告",{"_72":73,"_15":74},"zh","

UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date of report: November 2, 2026

Commission File Number: 001-38974

BIOPHYTIS S.A.

(Translation of registrant’s name into\nEnglish)

Stanislas Veillet
\nBiophytis S.A.

Silver Innov

54 rue Molière

94200 Ivry sur Seine, France

+33 1 76 28 40 83

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual\nreports under cover of Form 20-F or Form 40-F:

x Form 20-F ¨ \nForm 40-F

Indicate by\ncheck mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by\ncheck mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On October 30, 2026, Biophytis S.A. issued its Half-Year Financial\nReport. A copy of Half-Year Financial Report is attached as Exhibit 99.1 to this Form 6-K.

EXHIBIT LIST

\n \n \n \n \n \n \n \n \n

Exhibit		Description
99.1		Half-Year Financial Report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

	BIOPHYTIS S.A.

Date: November 2, 2026	By:	/s/ Stanislas Veillet
		Name: Stanislas Veillet
		Title: Chairman and Chief Executive Officer

","zhKind","complete","公司与财报","财报","aihot","/items/hqriajwln432riu7ut3b2cpoh","https://www.sec.gov/Archives/edgar/data/1768946/000110465926120965/0001104659-26-120965-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1794873600&sig=187d1741eb567c1f","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1794873600&sig=bf6a936df2e54c4a 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1794873600&sig=732799f81e0d268a 96w","changelogVersion","2026-10-01T08:00"]